7. Vaccine should be deferred for the appropriate interval if replacement immune globulin products are being administered (see “Table 3-5. Recommended Intervals Between Administration of Antibody-Containing Products and Measles- or Varicella-Containing Vaccine, by Product and Indication for Vaccination” found in “Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP),” available at -recs/index.html.)8. Measles vaccination might suppress tuberculin reactivity temporarily. Measles-containing vac-cine may be administered on the same day as tuberculin skin testing or interferon gamma re-lease assay (IGRA), or should be postponed for at least 4 weeks after the vaccination. 9. HPV vaccine is not recommended for use in pregnant women. If a woman is found to be preg-nant after initiating the vaccination series, the remainder of the series should be delayed until completion of pregnancy. Pregnancy testing is not needed before vaccination.10. For additional information on use of influenza vaccines among persons with egg allergy, see CDC. “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) – United States, . . .” Access links to influ-enza vaccine recommendations at .11. LAIV is not recommended for people with functional or anatomic asplenia, complement com- ponent deficiency, cochlear implant, or CSF leak.footnotesImmunization Action Coalition•Saint Paul, Minnesota•651-647-9009•••Item #P3072a (4/19)Guide to Contraindications and Precautions to Commonly Used Vaccines1,*(continued) PAGE 2 OF 2
You've reached the end of your free preview.
Want to read both pages?
- Summer '17
- severe combined immunodeficiency, Immunodeficiency, Severe allergic